10-KSMMTCIK 0001599298

Summit Therapeutics Inc.

Name: SEC EDGAR filing 0001599298-24-000031
Creator: Summit Therapeutics Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed February 20, 2024.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001599298-24-000031
Filer: Summit Therapeutics Inc.
Ticker: SMMT
CIK: 0001599298
Form type: 10-K
Form description: Annual report
Filed at: February 20, 2024
Period of report: December 31, 2023
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 10.0 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Summit Therapeutics Inc.

See all 44 filings from Summit Therapeutics Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1599298/000159929824000031/0001599298-24-000031-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Summit Therapeutics Inc. (0001599298) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.